S
Sun Pharmaceutical
SUNPHARMA Share Price
Healthcare1,801.60
as on 13 Mar 2026 at 15:59
Market Cap
₹4,32,264 Cr
PE Ratio
40.00
ROCE
18.92%
SUNPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
4,32,264
PE Ratio
40.00
PB Ratio
5.63
Dividend Yield
0.88%
ROE
15.15%
ROCE
18.92%
Book Value (₹)
324.34
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 54.48% | 54.48% | 54.48% | 54.48% | 54.48% |
| Domestic Institutional Investors (DII) | 18.55% | 18.70% | 19.50% | 20.24% | 20.82% |
| Foreign Institutional Investors (FII) | 18.05% | 17.96% | 17.26% | 16.55% | 16.12% |
| Public Investors | 5.47% | 5.42% | 5.35% | 5.53% | 5.40% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
SUNPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Largecap
BSE Scrip Code
524715
NSE Scrip Name
SUNPHARMA
ISIN
INE044A01036



